0.6884
1.26%
-0.0088
Pre-mercato:
.70
0.0116
+1.69%
Precedente Chiudi:
$0.6972
Aprire:
$0.6973
Volume 24 ore:
87,179
Relative Volume:
1.35
Capitalizzazione di mercato:
$20.61M
Reddito:
$38.25M
Utile/perdita netta:
$-17.87M
Rapporto P/E:
-9.8343
EPS:
-0.07
Flusso di cassa netto:
$4.33M
1 W Prestazione:
+8.07%
1M Prestazione:
+11.03%
6M Prestazione:
-36.26%
1 anno Prestazione:
-37.98%
Retractable Technologies Inc Stock (RVP) Company Profile
Nome
Retractable Technologies Inc
Settore
Industria
Telefono
972-294-1010
Indirizzo
511 Lobo Lane, Little Elm, TX
Confronta RVP con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
RVP
Retractable Technologies Inc
|
0.6884 | 20.61M | 38.25M | -17.87M | 4.33M | -0.61 |
ISRG
Intuitive Surgical Inc
|
521.96 | 185.91B | 7.87B | 2.24B | 586.00M | 6.22 |
BDX
Becton Dickinson Co
|
226.87 | 65.59B | 20.18B | 1.71B | 3.07B | 5.94 |
ALC
Alcon Inc
|
84.89 | 41.99B | 9.76B | 1.16B | 665.00M | 2.34 |
RMD
Resmed Inc
|
228.69 | 33.57B | 4.81B | 1.11B | 1.35B | 7.55 |
WST
West Pharmaceutical Services Inc
|
327.56 | 23.72B | 2.88B | 499.60M | 321.60M | 6.74 |
Retractable Technologies Inc Borsa (RVP) Ultime notizie
Retractable Technologies declares dividends to CPS holders - Medical Buyer
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders - Defense World
Retractable Technologies Announces Q4 2024 Preferred Stock Dividend Payment Schedule - StockTitan
Retractable Technologies CEO Thomas Shaw buys $336 in shares By Investing.com - Investing.com Canada
Head to Head Contrast: Retractable Technologies (NYSE:RVP) vs. Titan Medical (NASDAQ:TMDIF) - Defense World
Retractable Technologies (NYSE:RVP) Earns Hold Rating from Analysts at StockNews.com - Defense World
Retractable Technologies CEO Thomas Shaw acquires $1,550 in stock - Investing.com
Retractable Technologies CEO Thomas Shaw buys $17,927 in stock By Investing.com - Investing.com Canada
Retractable Technologies CEO Thomas Shaw buys $17,927 in stock - Investing.com
Blood Collection Devices Market: Trends, Size, Share, Growth, and Forecast to 2033 - WhaTech
Retractable Technologies (NYSE:RVP) Coverage Initiated by Analysts at StockNews.com - Defense World
Retractable Technologies Slashes Headcount by 10% - Marketscreener.com
Retractable Technologies CEO Thomas Shaw buys $213 in stock By Investing.com - Investing.com Australia
Retractable Technologies CEO Thomas Shaw buys $213 in stock - Investing.com
Retractable Technologies CEO Thomas Shaw buys $3,902 in stock By Investing.com - Investing.com Canada
Retractable Technologies CEO Thomas Shaw buys $3,902 in stock - Investing.com
Prefilled Safety Devices Market Generated Opportunities, - openPR
Layoffs in medtech: These companies recently reduced their workforce - Mass Device
Syringe Market Opportunity Analysis and Industry Forecast, 2024-2030 - openPR
Retractable Technologies CEO Thomas Shaw buys $12,372 in stock By Investing.com - Investing.com Canada
Retractable Technologies CEO Thomas Shaw buys $12,372 in stock - Investing.com
Safety Syringes Market: Safeguarding Healthcare with Advanced Needle Safety Solutions - openPR
Retractable Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Retractable Technologies reports loss of USD 5.1M in Q3 2024 - Medical Buyer
Retractable Technologies: Q3 Earnings Snapshot - New Haven Register
Retractable Technologies Inc (RVP) Quarterly 10-Q Report - Quartzy
Retractable Technologies, Inc. Results for the Periods Ended September 30, 2024 - The Bakersfield Californian
Retractable Technologies Reports Steep Q3 Loss as Margins Collapse, Tariffs Bite | RVP Stock News - StockTitan
Retractable Technologies CEO Thomas Shaw acquires $5,422 in stock - Investing.com
Retractable Technologies CEO Thomas Shaw acquires $8,150 in stock By Investing.com - Investing.com Australia
RVP stock touches 52-week low at $0.7 amid market challenges - Investing.com Australia
Retractable Technologies CEO Thomas Shaw acquires $8,150 in stock - Investing.com India
Disposable Syringes Market Overall Study Report 2024-2031 | B. - openPR
Feds Can Hold Proceeds During Chinese Syringe Duties Fight - Law360
Retractable Technologies CEO Thomas J. Shaw acquires $6,876 in stock - Investing.com
Head-To-Head Comparison: Neuronetics (NASDAQ:STIM) and Retractable Technologies (NYSE:RVP) - Defense World
Retractable Technologies CEO Thomas Shaw acquires $6,128 in stock - Investing.com
Retractable Technologies CEO Thomas Shaw acquires $6,128 in stock By Investing.com - Investing.com UK
Retractable Technologies Inc Azioni (RVP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):